STABLE-ISOTOPE DILUTION ASSAY FOR THE IN-VIVO DETERMINATION OF INSULIN LEVELS IN HUMANS BY MASS-SPECTROMETRY

Citation
R. Stocklin et al., STABLE-ISOTOPE DILUTION ASSAY FOR THE IN-VIVO DETERMINATION OF INSULIN LEVELS IN HUMANS BY MASS-SPECTROMETRY, Diabetes, 46(1), 1997, pp. 44-50
Citations number
45
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
00121797
Volume
46
Issue
1
Year of publication
1997
Pages
44 - 50
Database
ISI
SICI code
0012-1797(1997)46:1<44:SDAFTI>2.0.ZU;2-A
Abstract
Insulin levels in humans were measured by a new assay, the isotope dil ution assay (IDA), based on stable isotope dilution mass spectrometry. A known amount of a deuterated analog of insulin was used as an inter nal standard and added to the serum samples before sample processing, After isolation by immunoaffinity chromatography and solid phase extra ction, followed by a purification step on reversed-phase microbore hig h-performance liquid chromatography (HPLC), the insulin-containing fra ction was analyzed by mass spectrometry. The relative intensity of the signals due to insulin and its deuterated analog in the mass spectrum was used to determine the concentration of insulin in the sample, Usi ng serum samples of 0.5-2.0 ml, we were able to measure insulin levels in the range of 3-1700 pmol/l in several clinical samples from type I I diabetic patients, The basal level a endogenous insulin mas also det ermined in two normal subjects and found to be similar to 20 pmol/l, I nsulin secretion was followed after the ingestion of Bg glucose in one healthy volunteer, Finally the determination of the insulin level of one hemolyzed post-mortem blood sample, for which immunoassays gave in consistent results, was performed to help forensic investigations, Our results showed a good correlation with standard immunoassay data, exc ept in six samples where much lower values were obtained by our stable isotope dilution assay suggesting arm overestimation of insulin level s by immunoassay in some cases, As it is not subject to immunological interferences by insulin-related compounds, this nem assay has a major clinical advantage in that it avoids confusions related to hyperinsul inemia.